sara.feltesse@sciex.com

Discover How SWATH Acquisition Technology is Being Used in HIV-1 Research

Dec 1, 2015 | Blogs, Life Science Research, Proteomics | 0 comments

SWATH® Acquisition: On the Forefront of HIV-1 Research

World AIDS Day is held on the 1st December each year and is an opportunity for people worldwide to unite in the fight against HIV, show their support for people living with HIV, and to commemorate people who have died. World AIDS Day was the first ever global health day, held for the first time in 1988.

Source: http://www.worldaidsday.org/about

A research team at the University of Nebraska Medical Center (UNMC) is using SWATH Acquisition to advance a host-oriented antiviral strategy that targets the biomolecules required for viral replication.

Using SWATH for quantitative proteomics together with bioinformatic analyses to identify host proteins, the team quantified the expression of 3,608 proteins in uninfected and HIV-1-infected monocyte-derived microphages.

Of these, they found that 420 were significantly altered upon HIV-1 infection, and the findings highlighted a novel set of proteins and processes that are involved in the host response to HIV-1 infection.

Journal of Proteomics Research, 2014, April 4; Drs. P. Ciborowski, N. Haverland, H. Fox, University of Nebraska Medical Center or VIEW the webinar (May 2014) by Drs. Pawel Ciborowski and Nicole Haverland

In this informative presentation, you’ll learn:

How to design a SWATH spectral library for a nucleic acid binding protein interactome using whole cell lysates
A unique informatics strategy that takes advantage of SWATH measurement reproducibility to overcome biological variations in compared samples

Tips and tricks from our application experts: AAV analysis with CE

Peter Holper, Staff Applications Scientist at SCIEX, US, shares his tips and tricks on AAV analysis using CE with the BioPhase 8800 system and the PA 800 Plus system.

Pharma perspectives: The influence of LC-MS innovation on drug development outsourcing

It is no secret that (bio)pharmaceutical research and development is complex, both scientific and regulatory processes. Working for a contract research organization and more recently for SCIEX has provided an interesting perspective on trends the market experiences that affect many of us.

Overcoming uncertainty in your PFAS analysis

Just like gum on the bottom of a shoe, the existence of per- and poly-fluorinated alkyl substances (PFAS) in our environment is a sticky one. If you’re in the field of environmental testing, then you’re all too familiar with the threat these substances have on public health. While we have learned a lot about them over the years, there is still much more to understand. With the right detection methods, we can gather the information we need to empower us to make informed decisions on reducing the risks they impose.

Posted by

0 Comments

Submit a Comment Cancel reply

You must be logged in to post a comment.